Real-World Clinical Experience of Semaglutide in Secondary Care Diabetes: A Retrospective Observational Study

ConclusionSemaglutide provided clinically and statistically significant reductions in HbA1c, body weight, lipids and liver enzymes.
Source: Diabetes Therapy - Category: Endocrinology Source Type: research